Home About Us Products and Services Healthcare Professionals Non-Healthcare Professionals Guidelines News Contact Us IMAGINE... Frequently Asked Questions Product Support

Latest News

22nd May 2008

Study results confirm T-SPOT^®.TB performance is not affected by low CD4 count in HIV infected subjects

20th February 2008

Study results demonstrate ability of T-SPOT^®.TB to monitor declining response in subjects receiving
anti-TB treatment

29th October 2007

Oxford Immunotec completes $40M financing

09th October 2007

Study results confirm T-SPOT^®.TB is cost-effective in TB control programmes

IMAGINE...

To book a demo, click here

To attend a training course, click here

To request a copy of the business case, click here